GlassScriptPhysician profile
Sandee M Jacobs
NPI 1184954034
$943.36
in general payments reported to CMS, 2019-2025
15 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.76 · 2022: $130 · 2023: $295 · 2024: $321 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $191.84 | 2022-2024 | Quviviq |
| Collegium Pharmaceutical, INC. | $133.46 | 2022-2025 | Belbuca, Xtampza |
| Merck Sharp & Dohme LLC | $132.06 | 2022-2023 | Belsomra |
| Saluda Medical Americas, INC. | $91.33 | 2024-2025 | Evoke |
| Averitas Pharma INC. | $88.14 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $58.91 | 2025 | |
| Boston Scientific Corporation | $57.66 | 2024-2025 | Wavewriter Alpha Prime 16, Intracept |
| Piramal Critical Care | $37.81 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.85 | 2022-2024 | Relistor |
| Abbvie INC. | $28.01 | 2025 | |
| Abbott Laboratories | $26.37 | 2022 | |
| Spr Therapeutics, INC | $24.01 | 2023 | Sprint Pns System |
| Azurity Pharmaceuticals, INC. | $16.43 | 2022 | |
| Pfizer INC. | $14.76 | 2021 | |
| Nevro Corp. | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandee Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.